Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Lobmaier

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Addiction (Abingdon, England)|June 16, 2005
Blame the counselling, not the implant. A response to Oliver, Horspool & Keen (2005)Nikolaj Kunøe, Philipp Lobmaier
Harm Reduction Journal|June 18, 2022
Who is using take-home naloxone? An examination of supersaversDesiree Eide, Philipp Lobmaier, Thomas Clausen
Drug and Alcohol Dependence Reports|February 27, 2023
An evaluation of eight short versions of the Drug Use Disorder Identification Test (DUDIT). A prison population studyHilde Pape, Philipp Lobmaier, Anne Bukten
Drug and Alcohol Dependence|April 25, 2016
Utilizing a train-the-trainer model for multi-site naloxone distribution programsDesiree Madah-Amiri, Thomas Clausen, Philipp Lobmaier
Drug and Alcohol Dependence|February 10, 2017
Rapid widespread distribution of intranasal naloxone for overdose preventionDesiree Madah-Amiri, Thomas Clausen, Philipp Lobmaier
European Journal of Clinical Pharmacology|February 20, 2010
The pharmacological treatment of opioid addiction--a clinical perspectivePhilipp Lobmaier, Michael Gossop, Helge Waal, et al.
British Journal of Clinical Pharmacology|October 24, 2012
Injectable and implantable sustained release naltrexone in the treatment of opioid addictionNikolaj Kunøe, Philipp Lobmaier, Hanh Ngo, et al.
Drug and Alcohol Dependence|January 16, 2024
Mortality risk and causes of death among people who use opioids in a take-home naloxone cohortØystein Bruun Ericson, Desiree Eide, Philipp Lobmaier, et al.
Drug and Alcohol Dependence|October 3, 2022
Risks and overdose responses: Participant characteristics from the first seven years of a national take-home naloxone programØystein Bruun Ericson, Desiree Eide, Philipp Lobmaier, et al.
Substance Abuse Treatment, Prevention, and Policy|February 17, 2022
Staff preferences towards electronic data collection from a national take-home naloxone program: a cross-sectional studyØystein Bruun Ericson, Desiree Eide, Philipp Lobmaier, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Addiction (Abingdon, England)|June 16, 2005
Blame the counselling, not the implant. A response to Oliver, Horspool & Keen (2005)Nikolaj Kunøe, Philipp Lobmaier
Harm Reduction Journal|June 18, 2022
Who is using take-home naloxone? An examination of supersaversDesiree Eide, Philipp Lobmaier, Thomas Clausen
Drug and Alcohol Dependence Reports|February 27, 2023
An evaluation of eight short versions of the Drug Use Disorder Identification Test (DUDIT). A prison population studyHilde Pape, Philipp Lobmaier, Anne Bukten
Drug and Alcohol Dependence|April 25, 2016
Utilizing a train-the-trainer model for multi-site naloxone distribution programsDesiree Madah-Amiri, Thomas Clausen, Philipp Lobmaier
Drug and Alcohol Dependence|February 10, 2017
Rapid widespread distribution of intranasal naloxone for overdose preventionDesiree Madah-Amiri, Thomas Clausen, Philipp Lobmaier
European Journal of Clinical Pharmacology|February 20, 2010
The pharmacological treatment of opioid addiction--a clinical perspectivePhilipp Lobmaier, Michael Gossop, Helge Waal, et al.
British Journal of Clinical Pharmacology|October 24, 2012
Injectable and implantable sustained release naltrexone in the treatment of opioid addictionNikolaj Kunøe, Philipp Lobmaier, Hanh Ngo, et al.
Drug and Alcohol Dependence|January 16, 2024
Mortality risk and causes of death among people who use opioids in a take-home naloxone cohortØystein Bruun Ericson, Desiree Eide, Philipp Lobmaier, et al.
Drug and Alcohol Dependence|October 3, 2022
Risks and overdose responses: Participant characteristics from the first seven years of a national take-home naloxone programØystein Bruun Ericson, Desiree Eide, Philipp Lobmaier, et al.
Substance Abuse Treatment, Prevention, and Policy|February 17, 2022
Staff preferences towards electronic data collection from a national take-home naloxone program: a cross-sectional studyØystein Bruun Ericson, Desiree Eide, Philipp Lobmaier, et al.
Pageof 2